Focus: Route 92 Medical is a public medical device company specializing in catheter technology for acute ischemic stroke treatment, headquartered in San Mateo, CA. The company operates in the neurology space with FDA-cleared reperfusion systems currently in commercial deployment.
Profile data last refreshed 4h ago · AI intelligence enriched 3w ago
Cooling — net -5 jobs in 30d
11 added, 16 removed. Slower than typical.
Route 92 Medical is a post-commercial device company in growth mode with strong recent financing, but limited public clinical evidence and early-stage commercial infrastructure make this a bet on execution rather than proven market traction.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Route 92 Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Route 92 Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Route 92 Medical Announces First Commercial Cases in Canada - GlobeNewswire
Route 92 Medical Announces First Commercial Cases in Canada GlobeNewswire
Route 92 Medical Announces Appointment of Raj Denhoy as Chief Financial Officer - GlobeNewswire
Route 92 Medical Announces Appointment of Raj Denhoy as Chief Financial Officer GlobeNewswire
Route 92 Medical raises $50m to support growth strategy - Medical Device Network
Route 92 Medical raises $50m to support growth strategy Medical Device Network
Apnimed Secures Up to $150MM in Debt Financing with HealthCare Royalty Partners - ABF Journal
Apnimed Secures Up to $150MM in Debt Financing with HealthCare Royalty Partners ABF Journal
Route 92 Medical brings in $50M growth financing - MassDevice
Route 92 Medical brings in $50M growth financing MassDevice
Route 92 Medical Announces $50 Million Growth Financing - GlobeNewswire
Route 92 Medical Announces $50 Million Growth Financing GlobeNewswire
Showing 6 of 7 news items
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
The novel Tenzing 7 delivery catheter designed to deliver intermediate catheters to the face of embolus without crossing: clinical performance predicted in anatomically challenging model.
Preventing vessel perforations in endovascular thrombectomy: feasibility and safety of passing the clot with a microcatheter without microwire: the wireless microcatheter technique.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo